MASS 908 Devices Inc.
Price Chart
Executive Summary
908 Devices completed the acquisition of NIRLAB AG for $15M upfront ($13M cash + $2M stock) plus up to $8M in earn-out shares, and reported Q1 2026 revenue of $13.4M (+14% YoY) with a net loss of $12.0M. The company raised its full-year 2026 revenue guidance to $67M-$70M (19%-25% growth), reflecting confidence in the combined business. The acquisition adds a recurring subscription-based narcotics detection platform, expanding the total addressable market.
Key Financial Metrics
Actionable Insight
The combination of a beat-and-raise quarter with a strategically bolt-on acquisition that expands recurring revenue and international exposure is a strong catalyst. Watch for NIRLAB's contribution to Q2 results and progress toward the $8M earn-out milestones tied to government contracts. The 180-day lock-up on seller shares limits near-term overhang.
Key Facts
- Acquired NIRLAB AG for $15M upfront ($13M cash + 293,368 shares) plus up to $8M in earn-out shares tied to 2027 revenue milestones
- Q1 2026 revenue $13.4M, +14% YoY; recurring revenue $4.0M (30% of total)
- Raised FY2026 revenue guidance to $67M-$70M (19%-25% growth), up from prior $64.5M-$67.5M
- Adjusted gross margin improved 290 bps to 57% in Q1 2026
- Cash position $111.7M with no debt; NIRLAB acquisition funded from balance sheet
- NIRLAB adds AI-powered NIR spectroscopy for narcotics detection with over 1M field analyses and a high-retention subscription model
Financial Impact
$15M upfront plus up to $8M earn-out; Q1 revenue $13.4M (+14% YoY); guidance raised to $67M-$70M
Risk Factors
- Integration risk with Swiss-based NIRLAB (15 employees, new geography)
- Earn-out milestones depend on securing government contracts by Dec 2027 — execution risk
- Net loss from continuing operations widened to $12.0M in Q1 2026 vs $9.8M in Q1 2025
- Stock-based compensation and contingent consideration volatility may distort GAAP earnings
Market Snapshot
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-055912 |
| Document: tm2613572d1_ex99-1.htm | 0001104659-26-055912 |
| Document: tm2613572d1_8k.htm | 0001104659-26-055912 |
| Document: tm2613572d1_ex99-2.htm | 0001104659-26-055912 |
| Document: 0001104659-26-055912-index-headers.html | 0001104659-26-055912 |
| Document: 0001104659-26-055912-index.html | 0001104659-26-055912 |
| Document: 0001104659-26-055912.txt | 0001104659-26-055912 |
| 8-K Data (Synthetic) | 0001104659-26-055912 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 6, 2026
17d ago
|
8-K
| $8.06 $7.65 | ▼ −5.09% | ▼ −6.22% | $7.28 (−9.68%) |
|
May 6, 2026
18d ago
|
Insider Cluster
| $8.06 $7.65 | ▼ −5.09% | ▼ −6.22% | $7.28 (−9.68%) |
|
May 1, 2026
23d ago
|
Insider Cluster
| $6.81 $8.17 | ▲ +19.97% | ▲ +17.62% | $7.28 (+6.90%) |
|
Apr 10, 2026
6w ago
|
Insider Cluster
| $7.14 $7.16 | ▼ −0.28% | ▲ +4.22% | $7.28 (−1.96%) |
|
Mar 16, 2026
9w ago
|
EFFECT
| $6.09 $6.11 | ▲ +0.33% | ▲ +2.37% | $7.28 (+19.54%) |
|
Mar 9, 2026
10w ago
|
S-3
| $6.37 $6.09 | ▲ +4.32% | ▲ +2.97% | $7.28 (−14.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access